<DOC>
	<DOCNO>NCT00000731</DOCNO>
	<brief_summary>To determine zidovudine ( AZT ) acetaminophen ( APAP ) interact give patient , , manner interaction . Patients AIDS often require therapy painkiller management mild pain discomfort associate disease , APAP often prescribe . AZT use treat AIDS patient . It important doctor understand AZT APAP may interact give patient , study suggest dosage AZT may adjust give APAP order avoid minimize adverse effect .</brief_summary>
	<brief_title>Evaluation Interaction Between Acetaminophen Zidovudine</brief_title>
	<detailed_description>Patients AIDS often require therapy painkiller management mild pain discomfort associate disease , APAP often prescribe . AZT use treat AIDS patient . It important doctor understand AZT APAP may interact give patient , study suggest dosage AZT may adjust give APAP order avoid minimize adverse effect . Persons infect HIV symptom ( fever , fatigue , weight loss ) AIDS eligible study . They give AZT orally every 4 hour APAP orally every 8 hour alone combination 4 day home . On 4th day , participant admit clinical research center study determine tolerate medicine . On 5th day , schedule 8 dos AZT give intravenously , schedule dos APAP still give orally . Repeated blood sample take next 12 hour urine collect 24 hour . The process repeat weekly interval 3 week , patient receives AZT alone , APAP alone , combination AZT APAP .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition : Patients follow exclude : Severe ongoing opportunistic infection include Pneumocystis carinii pneumonia ( PCP ) , cryptococcal toxoplasmosis meningoencephalitis , disseminate herpes simplex herpes zoster . A demonstrated prior sensitivity experience significant adverse effect prior therapy drug use study . Significant diarrhea entry ( &gt; 1 watery stool/day ) . Patients follow exclude : Severe ongoing opportunistic infection include Pneumocystis carinii pneumonia ( PCP ) , cryptococcal toxoplasmosis meningoencephalitis , disseminate herpes simplex herpes zoster . A demonstrated prior sensitivity experience significant adverse effect prior therapy drug use study . Significant diarrhea entry ( &gt; 1 watery stool/day ) . AIDS relate complex ( ARC ) define presence one follow within 12 month prior entry absence concurrent illness condition HIV infection explain finding : Fever &gt; 38.5 degree C persist longer 3 week . Involuntary weight loss &gt; 15 lb . &gt; 10 percent baseline note 120day period prior evaluation . History diarrhea ( &gt; 2 liquid stool per day ) persisting longer 1 month occur entry . History clinical diagnosis oral candidiasis hairy leukoplakia . Patients AIDSdefined opportunistic infection tumor . Patients eligible zidovudine labeling . A positive HIV antibody test . Exceptions make patient previously positive HIV antibody test progressive disease patient virus isolation make . A life expectancy least 3 month . Patients stable Kaposi 's sarcoma , mild herpes infection , mild stable depression , asymptomatic mild cytomegalovirus EpsteinBarr virus infection , hepatitis B virus carrier state acceptable study . Inability abstain alcohol drug , include nonprescription medication , study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Acetaminophen</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>